Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

• 1. Part one: History, discovery and Taxonomy of viruses-tumor complications2. Part two: Taxonomy and classification of oncoviruses: Structural organization, Genetic organization, Oncoviruses Morphology in electronic microscopy3. Part three: Oncoviruses around the world: epidemiology statistics; current methods and studies of oncoviruses. 4. Part four: DNA oncoviruses: A. Molecular epidemiology (Papillomaviridae Polyomaviridae (JC, BK, SIV), Adenoviridae, Herpesviridae, Hepadnaviridae)B. Cancer implications and associations: (Human papilloma virus (HPV), Kaposi's sarcoma-associated herpes virus, Epstein–Barr virus (EBV or HHV-4), Merkel cell polyoma virus , Human cytomegalovirus (CMV or HHV-5)5. Part five: RNA oncoviruses: A. molecular epidemiology (Retroviridae , Flaviviridae)B. Cancer implications and associations: (Mammary mouse tumor viruses (MMTV), Human T-lymphotropic virus (HTLV1,), hepatitis C virus and hepatocarcinoma, retroviruses, Rous sarcoma virus (RSV)).

Select Guide Rating